Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey
D Niederwieser(University Hospital of Basel), Minako Iida(Aichi Medical University), Jakob Passweg, A Gratwohl(University of St.Gallen), Helen Baldomero, Mohamad Mohty(Inserm), Michael Gratwohl(University of St.Gallen), Jeff Szer(The Royal Melbourne Hospital), Y Kodera(Aichi Medical University), Yoshiko Atsuta(Aichi Medical University), Adriana Seber(Support group for adolescents and children with cancer), Nicolás Novitzky, Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Marcelo C. Pasquini(Medical College of Wisconsin), Mary M. Horowitz(Medical College of Wisconsin), Hildegard Greinix(Medical University of Graz), Jane Apperley(Hammersmith Hospital), J. H. Lipton(Princess Margaret Cancer Centre), Dennis L. Confer(University of Michigan–Ann Arbor), Luís Fernando S. Bouzas(Instituto Nacional de Câncer - INCA)
Cited by 309
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859